M. Marotti

An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects

W. Fahy, C. Beaumont, A. Harrell, 2019, Drug Metabolism and Disposition.

Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase δ Inhibitor

D. Mallett, A. Harrell, A. Cahn, 2019, The Journal of Pharmacology and Experimental Therapeutics.

COPD_A_309320 1637..1646

W. Fahy, S. West, W. Meeraus, 2021 .

Drug Interactions for Low-Dose Inhaled Nemiralisib: A Case Study Integrating Modeling, In Vitro, and Clinical Investigations

A. Harrell, K. Riddell, Kunal S. Taskar, 2020, Drug Metabolism and Disposition.

Severe cutaneous adverse reactions (SCAR) syndromes.

M. Marotti, 2012, Revista da Associacao Medica Brasileira.

At The Bedside; Pharmaceutical MedicineSevere cutaneous adverse reactions (SCAR) syndromes

M. Marotti, 2012 .

Severe cutaneous adverse reactions (SCAR) syndromes.

M. Marotti, 2012, Revista da Associacao Medica Brasileira.